Rare diseases
Investigational molecules
Locations
645 Summer Street Suite 200, 02210-2135, United States
Akouos Inc. concentrates its research efforts on developing innovative therapeutic approaches for inherited forms of hearing loss. The organization's clinical programs target specific genetic mutations that cause sensorineural hearing loss, focusing on conditions where the underlying genetic defect has been clearly identified. This work represents a pioneering effort in addressing congenital hearing impairment through targeted molecular interventions.
The sponsor's research portfolio demonstrates a commitment to advancing precision medicine approaches for patients with genetically-defined auditory dysfunction, seeking to restore or preserve hearing function through novel therapeutic modalities.
Akouos Inc. runs clinical trials in conditions such as Deafness, among others.
Clinical trials run by this sponsor – those enrolling participants first.
SpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
